Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
24.82
+0.82 (3.42%)
At close: Mar 9, 2026, 4:00 PM EDT
24.70
-0.12 (-0.48%)
After-hours: Mar 9, 2026, 6:20 PM EDT

Arcutis Biotherapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3,0793,5821,6423139031,042
Market Cap Growth
95.99%118.17%425.11%-65.39%-13.33%-14.50%
Enterprise Value
2,9723,4741,523245.02694.42730.82
Last Close Price
24.8229.0413.933.2314.8020.74
PE Ratio
--223.38-12.01-0.85-2.61-4.96
Forward PE
67.6076.62----
PS Ratio
8.199.528.355.24245.08-
PB Ratio
16.1618.9010.423.534.313.50
P/TBV Ratio
16.6719.5010.702.533.893.44
P/FCF Ratio
--567.51-14.62-1.26-3.50-5.93
P/OCF Ratio
--636.73-14.64-1.27-3.51-5.97
EV/Sales Ratio
7.909.247.754.11188.39-
EV/EBITDA Ratio
--459.46-12.04-1.02-2.31-3.55
EV/EBIT Ratio
--284.09-11.86-1.02-2.30-3.54
EV/FCF Ratio
--550.39-13.56-0.99-2.69-4.16
Debt / Equity Ratio
0.600.600.702.310.960.26
Debt / EBITDA Ratio
-15.42-15.11-0.87-0.86-0.67-0.38
Debt / FCF Ratio
-18.10-18.10-0.98-0.83-0.78-0.44
Net Debt / Equity Ratio
-0.56-0.56-0.75-0.75-0.99-1.04
Net Debt / EBITDA Ratio
14.4614.160.940.280.691.51
Net Debt / FCF Ratio
16.9716.971.060.270.811.77
Asset Turnover
0.960.960.570.150.010
Inventory Turnover
1.971.971.380.480.20-
Quick Ratio
2.832.833.726.4011.0911.66
Current Ratio
3.173.174.157.0811.5712.09
Return on Equity (ROE)
-9.30%-9.30%-113.76%-175.79%-122.80%-72.62%
Return on Assets (ROA)
-3.37%-3.37%-37.38%-61.72%-70.36%-58.47%
Return on Invested Capital (ROIC)
-21.59%-21.59%-416.44%-2037.82%5010.00%1745.95%
Return on Capital Employed (ROCE)
-4.28%-4.28%-45.65%-68.28%-76.72%-63.50%
Earnings Yield
-0.52%-0.45%-8.33%-117.03%-38.24%-20.15%
FCF Yield
-0.20%-0.18%-6.84%-79.16%-28.57%-16.85%
Buyback Yield / Dilution
-0.19%-0.19%-10.12%-32.41%-19.81%-20.11%
Updated Feb 25, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q